Home / Knowledge Centre /
Almac Voice

Rejecting Rejection: The CCL18-CCR8 pathway may be key to stopping transplantation rejection symptoms.

In secrets that were never revealed to us, Viktor learns the elusive chemistry of limb transplantation in Mary Shelly’s Frankenstein. Now, over 200 years later, we grow ever closer to uncovering those secrets in the form of vascularised composite allotransplantation (VCA), a procedure which allows the transplantation of full limbs from donor to recipient from the bone to the muscle, blood vessels, nerves, and skin.

View Resource
Almac Logo

Almac API, Chemical Development, Analytical & Solid State Services

Almac Sciences provides integrated services from development to commercial scale of advanced intermediates and Active Pharmaceutical Ingredients (API).

We provide a range of services for small molecules (including highly potent) and peptides. We have a proven track record of saving time and cost through the integration of our services and application of innovative biocatalysis and technology solutions.

Learn More

We offer a full suite of analytical testing for a range of different product types including small molecules, peptides, biologics, conjugates, potent and controlled substances.

Our vast pool of scientific knowledge can help to overcome the analytical challenges that typically arise during drug development.

Learn More

Download here instantly

This website uses cookies. By continuing to browse the site, you are agreeing to our use of cookies